Oral and Maxillofacial Lesions in COVID 19 Infection from Mosul Hospital in Iraq: Epidemiological Study and Approach to Classification and Treatment

• Main Authors: Alyaa Ismael Naser (Author), Marwa Nazar Al-Sarraj (Author), Ziad H. Deleme (Author)
• Format: Book
• Published: Universidad de Concepción., 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: https://doi.org/10.17126/joralres.2021.069; 0719-2460; 0719-2479
• Keywords: covid-19; oral ulcer; incidence; diabetes mellitus; hyper-tension; prospective studies; Dentistry; RK1-715
• Source: Journal of Oral Research, Vol 10, Iss 6, Pp 1-14 (2021)

During the COVID-19 pandemic, many manifestations of the disease appear in the oral, perioral and maxillofacial regions, either related to the virus itself or to the drugs used in the treatment. Aim: This study aims to identify the most common oral and perioral lesions in hospitalized patients with COVID-19 in the city of Mosul and their management; and also to evaluate the incidence and prevalence of these lesions. Material and Methods: Prospective study included 338 patients (138 females, 200 males) who had positive PCR results for SARS-CoV-2, with oral manifestations. All data were analyzed taking the means, frequencies, and percentage. Results: The most common lesions were colored lesions (31%) and stomatalgia (27%). The most common oral disorder and prior comorbidity combination was stomatalgia in patients with a history of hypertension. The most common associated systemic diseases were diabetes mellitus (19%) followed by hypertension (17%). Macular lesions had a higher response to drugs (40%) followed by stomatalgia (28%), in comparison with necrotic lesions (0%). Treatment of oral lesions included surgical interventions (26%) as well as conventional medical treatment (74%). Conclusion: Oral and perioral disorders during COVID-19 are transitory and more evidence is warranted to efficiently address these comorbidities in the short term.